Antonio P. Ciardella
NewYork–Presbyterian Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Antonio P. Ciardella.
American Journal of Ophthalmology | 2008
Neil M. Bressler; Allison R. Edwards; Andrew N. Antoszyk; Roy W. Beck; David J. Browning; Antonio P. Ciardella; Ronald P. Danis; Michael J. Elman; Scott M. Friedman; Adam R. Glassman; Jeffrey G. Gross; Helen K. Li; Timothy J. Murtha; Thomas W. Stone; Jennifer K. Sun
PURPOSE To evaluate optical coherence tomography (OCT) thickness of the macula in people with diabetes but minimal or no retinopathy and to compare these findings with published normative data in the literature from subjects reported to have no retinal disease. DESIGN Cross-sectional study. METHODS In a multicenter community- and university-based practices setting, 97 subjects with diabetes with no or minimal diabetic retinopathy and no central retinal thickening on clinical examination and a center point thickness of 225 microm or less on OCT (Stratus OCT; Carl Zeiss Meditec, Dublin, California, USA) were recruited. Electronic Early Treatment of Diabetic Retinopathy Study best-corrected visual acuity, seven-field stereoscopic color fundus photographs, and Stratus OCT fast macular scan were noted. Main outcome measures were central subfield (CSF) thickness measured on Stratus OCT. RESULTS On average, CSF thickness was 201 +/- 22 microm. CSF thickness was significantly greater in retinas from men than retinas from women (mean +/- standard deviation, 209 +/- 18 microm vs 194 +/- 23 microm; P < .001). After adjusting for gender, no additional factors were found to be associated significantly with CSF thickness (P > .10). CONCLUSIONS CSF thicknesses on Stratus OCT in people with diabetes and minimal or no retinopathy are similar to thicknesses reported from a normative database of people without diabetes. CSF thickness is greater in men than in women, consistent with many, but not all, previous reports. Studies involving comparisons of retinal thickness with expected norms should consider different mean values for women and men.
American Journal of Ophthalmology | 2003
Antonio P. Ciardella; William M. Schiff; Gaetano R. Barile; Orit Vidne; Janet R. Sparrow; Kevin Langton; Stanley Chang
PURPOSE To evaluate the persistence of indocyanine green (ICG) autofluorescence after ICG-assisted internal limiting membrane peeling for macular hole surgery. DESIGN Interventional case series. METHODS Retrospective institutional study. Four eyes of four patients who underwent pars plana vitrectomy with ICG-assisted internal limiting membrane peeling for macular hole repair were imaged for ICG autofluorescence at 795 nm with a scanning laser ophthalmoscope. The main outcome measure was persistence of ICG autofluorescence. RESULTS All four patients demonstrated persistent ICG fluorescence in the central macula up to 8 months postsurgery. CONCLUSIONS Persistent ICG signal was noted in the macula months after vitrectomy for macular hole surgery. The persistence of ICG autofluorescence could be responsible for delayed photochemical damage to the retinal pigment epithelium. Further studies must quantify the risk of retinal pigment epithelium injury when ICG-assisted internal limiting membrane peeling is used in macular hole surgery.
American Journal of Ophthalmology | 2003
Antonio P. Ciardella; Gaetano R. Barile; William M. Schiff; Lucian Del Priore; Kevin Langton; Stanley Chang
PURPOSE To report a case of stage IV macular hole associated with ruptured retinal arterial macroaneurysm. DESIGN Observational case report. METHOD The patients clinical, angiographic, and ophthalmic coherent tomography data were reviewed. RESULTS A stage IV macular hole was observed in association with a ruptured retinal arterial macroaneurysm in a 79-year-old patient. After vitrectomy surgery, the macular hole closed and vision improved from counting fingers to 20/100. CONCLUSIONS Macular hole associated with ruptured retinal macroaneurysm can be closed successfully to result in improved vision.
American Journal of Ophthalmology | 2003
Antonio P. Ciardella; Gaetano R. Barile; Kevin Langton; Stanley Chang
PURPOSE To report a case of cytomegalovirus (CMV) retinitis in a patient immunosuppressed with FK 506. DESIGN Interventional case report. METHODS Retrospective institutional study. One patient, diagnosed with bilateral CMV retinitis while on immunosuppressive treatment with FK 506, received systemic ganciclovir and intravitreal, slow-release ganciclovir implant in one eye, combined with reduction in FK 506 dose. Main outcome measures were visual acuity and regression of CMV retinitis. RESULTS Visual acuity at presentation was 20/20 in the right eye and 20/50 in the left eye. During the 6 months of follow-up, there was no change in visual acuity in either eye. The areas of CMV retinitis demonstrated progressive regression, leaving diffuse retinal atrophy. CONCLUSIONS Cytomegalovirus retinitis can be a sight-threatening complication of immunosuppressive treatment with FK 506. Ganciclovir treatment together with a reduction in FK 506 dose was effective in preserving vision.
American Journal of Ophthalmology | 2003
Antonio P. Ciardella; Kevin Langton; Stanley Chang
PURPOSE To report one case of intraocular emulsification of perfluorocarbon liquids (PFCLs) and silicone oil after vitrectomy surgery. DESIGN Interventional case report. METHODS Retrospective review of the clinic, and surgical record of a 39-year old female referred for persistent retinal detachment after vitrectomy surgery; PFCLs and silicone oil were left in the eye at the end of the surgery. RESULTS There was intraocular emulsification of PFCLs into silicone oil. Electron microscope examination of the silicone oil surgically extracted from the eye demonstrated emulsification of small PFCL bubbles into the silicone oil. CONCLUSION Perfluorocarbon liquids are surgical tools. They should be completely removed from the eye at the end of the surgery; PFCLs and silicone oil tend to emulsify together, originating an opaque fluid, which contains both silicone oil and dispersed PFCL bubbles.
Archives of Ophthalmology | 2006
Ronald P. Danis; Adam R. Glassman; Lloyd Paul Aiello; Andrew N. Antoszyk; Roy W. Beck; David J. Browning; Antonio P. Ciardella; James L. Kinyoun; Timothy J. Murtha; Trexler M. Topping; Shami M; George S. Sharuk; Wells Ja rd
American Journal of Ophthalmology | 2004
Antonio P. Ciardella; Grace C. Lee; Kevin Langton; Janet R. Sparrow; Stanley Chang
American Journal of Ophthalmology | 2007
Antonio P. Ciardella
American Journal of Ophthalmology | 2007
Antonio P. Ciardella
American Journal of Ophthalmology | 2005
Antonio P. Ciardella